• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday

    8/19/22 3:54:34 AM ET
    $ALLR
    $AURA
    $AXDX
    $BBBY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ALLR alert in real time by email

    Gainers

    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) shares climbed 135.9% to close at $2.17 on Thursday.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) shares climbed 53.9% to close at $0.8480
    • after the company announced it was awarded $17.6 million Product Development Research grant by the Cancer Prevention and Research Institute of Texas to fund radiotherapeutic, Rhenium-186 NanoLiposome.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) rose 49.6% to close at $2.02 after the company announced sales have outperformed Walmart's expectations.
    • Lizhi Inc. (NASDAQ:LIZI) gained 43.1% to settle at $1.76.
    • Endo International plc (NASDAQ:ENDP) jumped 42.9% to settle at $0.4057 after dipping 23% on Wednesday. Endo International filed for bankruptcy after reaching a $6 billion deal with some of its creditors as the company sought to settle opioid-related lawsuits.
    • Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) shares gained 36.2% to settle at $1.02 amid mention of the stock on Discord. Mind Medicine recently posted a Q2 loss of $0.04 per share.
    • Indonesia Energy Corporation Limited (NASDAQ:INDO) surged 33.3% to close at $7.80.
    • Wolfspeed, Inc. (NYSE:WOLF) shares surged 31.8% to settle at $112.91 after the company reported better-than-expected Q4 EPS and sales results. Additionally, multiple firms raised their price target on the stock.
    • Genius Group Limited (NYSE:GNS) jumped 28.2% to close at $8.18.
    • Weber Inc. (NYSE:WEBR) gained 27.2% to close at $10.00.
    • LightPath Technologies, Inc. (NASDAQ:LPTH) climbed 26.8% to close at $1.80.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) gained 25% to settle at $66.15.
    • Larimar Therapeutics, Inc. (NASDAQ:LRMR) surged 24.6% to close at $2.89. Larimar Therapeutics recently announced it received meeting minutes from the FDA following a recent Type C Meeting and plans to submit a complete response to the CTI-1601 clinical hold in Q3.
    • Horizon Global Corporation (NYSE:HZN) gained 24.5% to close at $2.39. Horizon Global recently posted a Q2 loss of $0.80 per share.
    • Edible Garden AG Incorporated (NASDAQ:EDBL) rose 22.9% to settle at $1.34. Edible Garden recently posted a Q2 loss of $0.68 per share.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) jumped 22.9% to close at $6.98.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 22.6% to close at $1.52.
    • Cyngn Inc. (NASDAQ:CYN) surged 21.5% to settle at $1.47. Cyngn recently posted a Q2 loss of $0.15 per share.
    • Seelos Therapeutics, Inc. (NASDAQ:SEEL) rose 21.5% to close at $1.13 as volume increases in psychedelic stocks.
    • Curis, Inc. (NASDAQ:CRIS) rose 20% to close at $1.26 after the company announced the U.S. FDA has lifted the partial clinical hold on the TakeAim Lymphoma Phase 1/2 study of emavusertib.
    • Milestone Pharmaceuticals Inc. (NASDAQ:MIST) gained 19.4% to close at $7.76. Milestone Pharmaceuticals recently posted a Q2 loss of $0.39 per share.
    • Mannatech, Incorporated (NASDAQ:MTEX) gained 17.1% to close at $23.50. Mannatech recently reported a second-quarter FY22 sales decline of 17.7% year-on-year, to $35 million.
    • Brooge Energy Limited (NASDAQ:BROG) surged 17% to settle at $8.45.
    • Canadian Solar Inc. (NASDAQ:CSIQ) jumped 15.2% to close at $45.19 after the company reported better-than-expected Q2 results and raised Q3 and FY22 sales guidance above estimates.
    • Mammoth Energy Services, Inc. (NASDAQ:TUSK) jumped 13.7% to close at $4.41.
    • Grindrod Shipping Holdings Ltd. (NASDAQ:GRIN) rose 13.2% to close at $21.70. Grindrod Shipping reported a second-quarter revenue increase of 47.1% year-over-year to $161.58 million.
    • Tellurian Inc. (NASDAQ:TELL) gained 13% to close at $4.68.
    • EQRx, Inc. (NASDAQ:EQRX) gained 12.6% to close at $5.43.
    • Silence Therapeutics plc (NASDAQ:SLN) gained 11.9% to close at $9.62.
    • Peabody Energy Corporation (NYSE:BTU) rose 11.5% to close at $25.90.
    • EnLink Midstream, LLC (NYSE:ENLC) climbed 9.9% to close at $10.81. The company recently posted upbeat quarterly sales.
    • Codiak BioSciences, Inc. (NASDAQ:CDAK) shares gained 9.1% to close at $2.52. Codiak BioSciences recently posted a Q2 loss of $0.30 per share.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) gained 8% to close at $9.89.
    • Helmerich & Payne, Inc. (NYSE:HP) gained 8% to settle at $44.00.
    • ON Semiconductor Corporation (NASDAQ:ON) rose 7.3% to close at $73.25 in sympathy with Wolfspeed, which reported better-than-expected Q4 EPS and sales results. Both companies are involved in making products in the auto sector.
    • BJ's Wholesale Club Holdings, Inc. (NYSE:BJ) climbed 7.2% to close at $74.09 after the company reported better-than-expected Q2 EPS and sales results and raised FY22 EPS guidance above estimates.
    • Keysight Technologies, Inc. (NYSE:KEYS) rose 6.2% to close at $179.70 as the company reported upbeat earnings for its third quarter and issued a strong forecast for the fourth quarter.
    • Cisco Systems, Inc. (NASDAQ:CSCO) rose 5.8% to settle at $49.37 after the company reported better-than-expected results for its fourth quarter and issued strong guidance.

     

    Losers

    • Blue Water Vaccines, Inc. (NASDAQ:BWV) shares fell 43.9% to close at $4.2850 on possible profit taking after the stock surged on Wednesday.
    • Unity Biotechnology, Inc. (NASDAQ:UBX) shares fell 37.1 to close at $0.6101 after the company reported pricing of upsized underwritten public offering.
    • TDH Holdings, Inc. (NASDAQ:PETZ) shares dipped 30.1% to settle at $2.98 after jumping 38% on Wednesday.
    • WeTrade Group, Inc. (NASDAQ:WETG) fell 28.5% to close at $5.12. WeTrade Group said, 'WeTrade and Zhixun are ready to launch an in-depth cooperative sales promotion of Zhixun's disinfectant.'
    • Accelerate Diagnostics, Inc. (NASDAQ:AXDX) fell 27.2% to close at $2.49 after the company announced the proposed public offering of its common stock.
    • ECMOHO Limited (NASDAQ:MOHO) dipped 26.1% to close at $0.1650.
    • America's Car-Mart, Inc. (NASDAQ:CRMT) declined 22.7% to close at $92.38 after the company reported worse-than-expected Q1 EPS results.
    • Veru Inc. (NASDAQ:VERU) fell 21.5% to close at $18.67.
    • GreenBox POS (NASDAQ:GBOX) dropped 21.1% to settle at $1.42.
    • LumiraDx Limited (NASDAQ:LMDX) dipped 20% to settle at $1.20 after the company reported worse-than-expected Q2 adjusted EPS and sales results.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) fell 19.6% to close at $18.55 following a Form 144 filing by RC Ventures, which suggested the firm proposed to sell 7.78 million common shares and certain call options. Additionally, Wedbush downgraded the stock to Underperform.
    • Kirkland's, Inc. (NASDAQ:KIRK) fell 18.6% to close at $5.21. The company is scheduled to report Q2 results on August 30, 2022.
    • Rite Aid Corporation (NYSE:RAD) dipped 18.5% to close at $8.57.
    • Nova LifeStyle, Inc. (NASDAQ:NVFY) dropped 18.1% to close at $0.9013.
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) fell 17.4% to close at $0.45. Zacks Small-Cap Research recently published a note on the stock with a $12 valuation.
    • Exscientia plc (NASDAQ:EXAI) fell 16.8% to close at $9.55 after the company reported worse-than-expected Q2 EPS results.
    • Party City Holdco Inc. (NYSE:PRTY) dropped 16.1% to settle at $1.98.
    • Cadiz Inc. (NASDAQ:CDZI) fell 16% to close at $4.26.
    • Eargo, Inc. (NASDAQ:EAR) fell 15.7% to close at $2.64 on possible profit taking after the stock surged on Wednesday.
    • Root, Inc. (NASDAQ:ROOT) fell 15.5% to close at $17.13.
    • Calliditas Therapeutics AB (publ) (NASDAQ:CALT) dropped 15.1% to close at $18.00
    • after the company reported worse-than-expected Q2 sales results.
    • Puhui Wealth Investment Management Co., Ltd. (NASDAQ:PHCF) declined 15% to close at $0.85.
    • CI&T Inc (NYSE:CINT) fell 14.8% to settle at $11.45 after Q2 results.
    • bluebird bio, Inc. (NASDAQ:BLUE) shares fell 14.3% to close at $5.81 The FDA has approved Bluebird bio’s Zynteglo (betibeglogene autotemcel), also known as beti-cel, a one-time gene therapy custom-designed for beta‑thalassemia.
    • Aura Biosciences, Inc. (NASDAQ:AURA) fell 13.5% to settle at $17.59. Aura Biosciences recently reported cash, cash on hand as of June 30, 2022 of $122.1 million.
    • Embark Technology, Inc. (NASDAQ:EMBK) dropped 13.4% to close at $11.42.
    • Lottery.com Inc. (NASDAQ:LTRY) fell 13.3% to close at $0.3641.
    • Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) fell 12.9% to close at $1.75. Cyclacel Pharmaceuticals recently said Q2 EPS results were up year over year.
    • VBI Vaccines Inc. (NASDAQ:VBIV) fell 11.4% to close at $1.09.
    • Soluna Holdings, Inc. (NASDAQ:SLNH) fell 11% to close at $3.48.
    • Hut 8 Mining Corp. (NASDAQ:HUT) fell 10% to close at $2.69 after the company launched at-the-market equity program of up to $200 million.
    • Big 5 Sporting Goods Corporation (NASDAQ:BGFV) fell 8.3% to settle at $8.57.
    • Walgreens Boots Alliance, Inc. (NASDAQ:WBA) dropped 5.3% to close at $38.24. It was reported on Wednesday the company and other pharmacy operators will be required to pay $650.6 million to two Ohio counties in an opioid case.
    Get the next $ALLR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALLR
    $AURA
    $AXDX
    $BBBY

    CompanyDatePrice TargetRatingAnalyst
    ON Semiconductor Corporation
    $ON
    4/23/2026$115.00Neutral → Buy
    B. Riley Securities
    Bright Minds Biosciences Inc.
    $DRUG
    4/13/2026$145.00Buy
    Jefferies
    ON Semiconductor Corporation
    $ON
    4/13/2026$85.00Neutral → Buy
    BofA Securities
    Milestone Pharmaceuticals Inc.
    $MIST
    4/10/2026$6.00Strong Buy
    Raymond James
    CI&T Inc
    $CINT
    4/9/2026$9.00Outperform
    Wedbush
    Keysight Technologies Inc.
    $KEYS
    3/31/2026$310.00Hold
    Truist
    Cisco Systems Inc.
    $CSCO
    3/31/2026$94.00Buy
    Truist
    Hut 8 Corp.
    $HUT
    3/23/2026$136.00Buy
    Arete
    More analyst ratings

    $ALLR
    $AURA
    $AXDX
    $BBBY
    SEC Filings

    View All

    SEC Form DEFA14A filed by Root Inc.

    DEFA14A - Root, Inc. (0001788882) (Filer)

    4/24/26 8:17:50 AM ET
    $ROOT
    Property-Casualty Insurers
    Finance

    SEC Form DEF 14A filed by Root Inc.

    DEF 14A - Root, Inc. (0001788882) (Filer)

    4/24/26 8:17:01 AM ET
    $ROOT
    Property-Casualty Insurers
    Finance

    SEC Form 6-K filed by Alpha Tau Medical Ltd.

    6-K - Alpha Tau Medical Ltd. (0001871321) (Filer)

    4/23/26 9:02:03 AM ET
    $DRTS
    Medical/Dental Instruments
    Health Care

    $ALLR
    $AURA
    $AXDX
    $BBBY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

    For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

    9/12/23 10:44:21 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    August 17, 2022 - FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions

    For Immediate Release: August 17, 2022 Today, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.  “Today’s approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing

    8/17/22 2:12:27 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Peterson Adam K

    4 - AMERICAS CARMART INC (0000799850) (Issuer)

    4/22/26 6:15:00 PM ET
    $CRMT
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form 4 filed by Daniels Eric Joseph

    4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)

    4/22/26 5:00:04 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Daniels Eric Joseph

    3 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)

    4/21/26 5:00:06 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    onsemi upgraded by B. Riley Securities with a new price target

    B. Riley Securities upgraded onsemi from Neutral to Buy and set a new price target of $115.00

    4/23/26 7:44:53 AM ET
    $ON
    Semiconductors
    Technology

    Jefferies initiated coverage on Bright Minds Biosciences with a new price target

    Jefferies initiated coverage of Bright Minds Biosciences with a rating of Buy and set a new price target of $145.00

    4/13/26 8:51:07 AM ET
    $DRUG
    Biotechnology: Pharmaceutical Preparations
    Health Care

    onsemi upgraded by BofA Securities with a new price target

    BofA Securities upgraded onsemi from Neutral to Buy and set a new price target of $85.00

    4/13/26 8:39:29 AM ET
    $ON
    Semiconductors
    Technology

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Tabacco Joseph J Jr bought $102,200 worth of shares (20,000 units at $5.11) (SEC Form 4)

    4 - BED BATH & BEYOND, INC. (0001130713) (Issuer)

    3/12/26 8:32:43 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    * Director by Deputization Flynn James E bought $25,000,000 worth of shares (5,000,000 units at $5.00) (SEC Form 4)

    4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)

    3/2/26 7:46:04 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Hamilton Thomas Edward bought $500,000 worth of shares (100,000 units at $5.00), increasing direct ownership by 18% to 664,798 units (SEC Form 4)

    4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)

    3/2/26 4:30:41 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sports Entertainment Gaming Global Corporation Receives Expected Notice from The NASDAQ Stock Market LLC Pertaining to its Form 10-K of December 31, 2025

    FORT WORTH, Texas, April 23, 2026 (GLOBE NEWSWIRE) -- On April 17, 2026, Sports Entertainment Gaming Global Corporation (NASDAQ:LTRY, LTRYW)) ("SEGG Media" or "the Company") received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of not having timely filed the Form 10-K for the period ended December 31, 2025 with the SEC, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), which requires timely filing of all required periodic financial reports with the SEC. Additionally, the Notice indicated that under the Nasdaq Listing Rules, the Company may submit a plan to regain compliance with the Listing Rule w

    4/23/26 5:29:00 PM ET
    $LTRY
    $SEGG
    Computer Software: Prepackaged Software
    Technology

    Grove to Report First Quarter 2026 Financial Results on May 7, 2026

    Grove Collaborative Holdings, Inc. (NYSE:GROV) ("Grove" or "the Company"), the world's first plastic-neutral retailer and a leading sustainable consumer products company, Certified B Corporation, and Public Benefit Corporation today announced that it will report first quarter 2026 financial results after the market closes on Thursday, May 7, 2026. The Company will host an investor conference call and webcast to review these financial results at 5:00pm ET / 2:00pm PT on the same day. The webcast can be accessed at https://investors.grove.co/. The conference call can be accessed by calling 877-413-7205. International callers may dial +1 201-689-8537. A replay of the call will be available u

    4/23/26 4:05:00 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    CI&T To Announce First Quarter 2026 Results on May 11, 2026

    CI&T Inc. (NYSE:CINT, "Company")), a global partner in tech-integrated business solutions, announces that it will report its first quarter 2026 financial results after the market closes on May 11, 2026. Following the earnings release, CI&T's senior management team will host a video conference call to discuss the financial and operating results on the same day, May 11, at 4:30 PM Eastern Time / 5:30 PM BRT. The video conference call can be accessed at the Company's Investor Relations website at investors.ciandt.com or through the following link: https://youtube.com/live/wsdGmWOVQY4?feature=share About CI&T CI&T (NYSE:CINT) is a global partner in tech-integrated business solutions for

    4/23/26 9:29:00 AM ET
    $CINT
    EDP Services
    Technology

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Leadership Updates

    Live Leadership Updates

    View All

    Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

    HOUSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announces that it has granted inducement awards to Eric J Daniels, M.D., its new Chief Development Officer who joined the Company on April 20, 2026. The awards were granted on April 20, 2026 under the Company's 2015 New Employee Incentive Plan, as amended, which provides for the granting of equity awards to new employees as an inducement to join the Company. The inducement awards consist of options to purchase 20,000 shares of the Company common

    4/22/26 4:30:00 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Wolfspeed Appoints Semiconductor Industry Veteran Yasuhisa Harita

    Wolfspeed, Inc. announced today the appointment of Yasuhisa Harita as regional president for Asia Pacific effective June 1, 2026. Harita will be based in Tokyo and lead Wolfspeed's commercial strategy across Japan, Korea and the ASEAN region with responsibility for driving revenue growth, enhancing strategic customer relationships, and executing the company's regional commercial and operational objectives. Harita brings more than 30 years of experience expanding Japan-based businesses for global semiconductor and technology companies, including Infineon and Micron. Most recently, he served as regional vice president at ams-OSRAM, where he accelerated revenue growth, strengthened customer

    4/22/26 9:00:00 AM ET
    $WOLF
    Semiconductors
    Technology

    Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution

    HOUSTON, April 15, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announces the appointment of Randy H. Goodman, Ph.D., M.H.A., as Vice President, Value Strategy & Health Economics and Outcomes Research (HEOR), effective April 13th, 2026. Dr. Goodman is a highly experienced health economics and market access leader with more than 20 years of experience spanning global pricing and reimbursement strategy, real-world evidence generation, and value-based healthcare modeling across the biotechnology, pharmaceutic

    4/15/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LightPath Technologies Inc.

    SC 13G/A - LIGHTPATH TECHNOLOGIES INC (0000889971) (Subject)

    12/13/24 3:18:07 PM ET
    $LPTH
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by CADIZ Inc.

    SC 13G/A - CADIZ INC (0000727273) (Subject)

    12/6/24 6:52:25 PM ET
    $CDZI
    Water Supply
    Utilities

    Amendment: SEC Form SC 13G/A filed by Wolfspeed Inc.

    SC 13G/A - WOLFSPEED, INC. (0000895419) (Subject)

    12/6/24 11:56:48 AM ET
    $WOLF
    Semiconductors
    Technology

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Financials

    Live finance-specific insights

    View All

    Grove to Report First Quarter 2026 Financial Results on May 7, 2026

    Grove Collaborative Holdings, Inc. (NYSE:GROV) ("Grove" or "the Company"), the world's first plastic-neutral retailer and a leading sustainable consumer products company, Certified B Corporation, and Public Benefit Corporation today announced that it will report first quarter 2026 financial results after the market closes on Thursday, May 7, 2026. The Company will host an investor conference call and webcast to review these financial results at 5:00pm ET / 2:00pm PT on the same day. The webcast can be accessed at https://investors.grove.co/. The conference call can be accessed by calling 877-413-7205. International callers may dial +1 201-689-8537. A replay of the call will be available u

    4/23/26 4:05:00 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    CI&T To Announce First Quarter 2026 Results on May 11, 2026

    CI&T Inc. (NYSE:CINT, "Company")), a global partner in tech-integrated business solutions, announces that it will report its first quarter 2026 financial results after the market closes on May 11, 2026. Following the earnings release, CI&T's senior management team will host a video conference call to discuss the financial and operating results on the same day, May 11, at 4:30 PM Eastern Time / 5:30 PM BRT. The video conference call can be accessed at the Company's Investor Relations website at investors.ciandt.com or through the following link: https://youtube.com/live/wsdGmWOVQY4?feature=share About CI&T CI&T (NYSE:CINT) is a global partner in tech-integrated business solutions for

    4/23/26 9:29:00 AM ET
    $CINT
    EDP Services
    Technology

    Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™

    HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announced today the initiation of manufacturing activities and technology transfer with SpectronRx under a previously executed Master Services Agreement (MSA), in support of late-stage clinical manufacturing of Rhenium-186 and REYOBIQ. With SpectronRx serving as a second GMP manufacturing site alongside Radiomedix, and Rhenium-186 isotope supplied through Telix Pharmaceuticals, Plus strengthens the reliability of its multi-partner supply chain

    4/23/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care